{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:54:38Z","timestamp":1778586878744,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jhep.2015.03.033","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T20:25:59Z","timestamp":1428265559000},"page":"554-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A"],"prefix":"10.1016","volume":"63","author":[{"given":"Sakura","family":"Akamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Nelson","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Aikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiiku","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.03.033_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/17474124.2015.960394","article-title":"Optimizing triple therapy and IFN\/RBV-free regimens for hepatitis C virus infection","volume":"9","author":"Chayama","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.03.033_b0010","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s12272-011-0921-6","article-title":"Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy","volume":"34","author":"Lee","year":"2011","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jhep.2015.03.033_b0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1874091X00903010039","article-title":"The hepatitis C virus NS5A stimulates NS5B during in vitro RNA synthesis in a template specific manner","volume":"3","author":"Quezada","year":"2009","journal-title":"Open Biochem J"},{"key":"10.1016\/j.jhep.2015.03.033_b0020","first-page":"41","article-title":"Approaches to hepatitis C treatment and cure using NS5A inhibitors","volume":"7","author":"Kohler","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jhep.2015.03.033_b0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1997.8493","article-title":"Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein","volume":"230","author":"Gale","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.jhep.2015.03.033_b0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1099\/vir.0.19513-0","article-title":"Hepatitis C virus NS5A protein interacts with 2\u2032,5\u2032-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner","volume":"85","author":"Taguchi","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0035","first-page":"219","article-title":"Innate immune responses to hepatitis C virus","volume":"369","author":"Schoggins","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2015.03.033_b0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2013.03.030","article-title":"NS5A inhibitors in the treatment of hepatitis C","volume":"59","author":"Pawlotsky","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.033_b0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2009.11.055","article-title":"Resistance to direct antiviral agents in patients with hepatitis C virus infection","volume":"138","author":"Sarrazin","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.03.033_b0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcv.2009.09.029","article-title":"Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir","volume":"47","author":"Suzuki","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0055","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3748\/wjg.v20.i11.2902","article-title":"Hepatitis C virus NS5A inhibitors and drug resistance mutations","volume":"20","author":"Nakamoto","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2015.03.033_b0060","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","article-title":"Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection","volume":"59","author":"Kumada","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.033_b0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2013.10.019","article-title":"Randomized trial of daclatasvir and asunaprevir with or without PegIFN\/RBV for hepatitis C virus genotype 1 null responders","volume":"60","author":"Lok","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.033_b0070","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s40265-014-0279-4","article-title":"Daclatasvir+asunaprevir: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jhep.2015.03.033_b0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/jmv.23207","article-title":"Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin","volume":"84","author":"Hayashi","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0080","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2012.11.012","article-title":"Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir","volume":"58","author":"Karino","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.033_b0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2012.09.037","article-title":"Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options","volume":"58","author":"Suzuki","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.033_b0090","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(14)61059-X","article-title":"All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study","volume":"384","author":"Manns","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2015.03.033_b0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jcv.2012.04.024","article-title":"Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b","volume":"54","author":"Suzuki","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0100","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1111\/hepr.12316","article-title":"Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection","volume":"44","author":"Miura","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2015.03.033_b0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.03.033_b0110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.03.033_b0115","doi-asserted-by":"crossref","first-page":"U1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.03.033_b0120","doi-asserted-by":"crossref","first-page":"e22649","DOI":"10.5812\/hepatmon.22649","article-title":"The impact of IFNL4 rs12979860 polymorphism on spontaneous clearance of hepatitis C. A case-control study","volume":"14","author":"Sharafi","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jhep.2015.03.033_b0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.03.033_b0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-lambda4: the paradoxical new member of the interferon lambda family","volume":"34","author":"O\u2019Brien","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jhep.2015.03.033_b0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis \u2013 Diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.033_b0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s100380170047","article-title":"A high-throughput SNP typing system for genome-wide association studies","volume":"46","author":"Ohnishi","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jhep.2015.03.033_b0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.03.033_b0150","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/jmv.20979","article-title":"Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b","volume":"79","author":"Akuta","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jmv.20507","article-title":"Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load","volume":"78","author":"Akuta","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis-C virus 1b \u2013 Sensitivity to interferon is conferred by amino-acid substitutions in the NS5A region","volume":"96","author":"Enomoto","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.03.033_b0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2015.03.033_b0170","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/jmv.23966","article-title":"Evolution of simeprevir-resistant variants over time by ultra-deep sequencing in HCV genotype 1b","volume":"86","author":"Akuta","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2015.03.033_b0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-deltag allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2015.03.033_b0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/bioinformatics\/btu587","article-title":"VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering","volume":"31","author":"Verbist","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2015.03.033_b0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/cmb.2012.0232","article-title":"Probabilistic inference of viral quasispecies subject to recombination","volume":"20","author":"Topfer","year":"2013","journal-title":"J Comput Biol"},{"key":"10.1016\/j.jhep.2015.03.033_b0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/gut.2010.223495","article-title":"HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy","volume":"60","author":"Hayes","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.03.033_b0195","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.1840220406","article-title":"Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C","volume":"22","author":"Martinot-Peignoux","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.03.033_b0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2010.10.032","article-title":"Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection","volume":"55","author":"Fried","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.03.033_b0205","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jhep.2015.03.033_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jnci\/djs458","article-title":"Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer","volume":"105","author":"Kohaar","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2015.03.033_b0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/bioinformatics\/btm537","article-title":"Multi-RELIEF: a method to recognize specificity determining residues from multiple sequence alignments using a Machine-Learning approach for feature weighting","volume":"24","author":"Ye","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2015.03.033_b0220","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2 \u2013 A multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2015.03.033_b0225","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/bioinformatics\/bti079","article-title":"HyPhy: hypothesis testing using phylogenies","volume":"21","author":"Pond","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhep.2015.03.033_b0230","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1471-2105-9-474","article-title":"RNAalifold: improved consensus structure prediction for RNA alignments","volume":"9","author":"Bernhart","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jhep.2015.03.033_b0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"IL28B polymorphism improves viral kinetics and is the strongest pre-treatment predictor of SVR in HCV-1 patients","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.03.033_b0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jhep.2015.03.033_b0245","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.chom.2014.01.007","article-title":"Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness","volume":"15","author":"Sheahan","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2015.03.033_b0250","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2015.03.033_b0255","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in IL28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.03.033_b0260","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.03.033_b0265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvh.12271","article-title":"Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1","volume":"22","author":"Kosaka","year":"2015","journal-title":"J Viral Hepat"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T12:25:07Z","timestamp":1656246307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0168827815002433"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.03.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}